Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
10/2005
10/26/2005CN1688548A Process for preparing quinolin antibiotic intermediates
10/26/2005CN1688543A Furanone derivatives and methods of making same
10/26/2005CN1688532A Composition based on substituted 1, 3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof
10/26/2005CN1688319A Use of corrinoids in the treatment of skin diseases
10/26/2005CN1224623C 1-phenysulfonyl-1, 3-dihydro-2H-indole-2-one derivatives, their preparation and their therapeutic use
10/26/2005CN1224614C Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands
10/26/2005CN1224598C Naphthalene derivatives
10/26/2005CN1224419C Orally administered peptides to ameliorate a therosclerosis
10/26/2005CN1224417C Combination of medication for external use for curing breach of skin
10/26/2005CN1224416C Chinese medicine for treating keloid
10/26/2005CN1224410C External use medicine for treating burn and scald and its preparation method
10/26/2005CN1224406C Medical ointment for treating athlete's foot
10/26/2005CN1224399C Medicinal Compsition for treating verrucosis
10/26/2005CN1224389C The use of scopolamine salts
10/25/2005US6958387 Human serpin polypeptides
10/25/2005US6958350 Chemical compounds
10/25/2005US6958349 Heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
10/25/2005US6958344 Pyrimidine compounds and their use as modulators of chemokine receptor activity
10/25/2005US6958343 Treating psoriasis, a disease in which angiogenesis is associated with raised CXCR2 chemokine levels, or COPD.
10/25/2005US6958336 Anticancer agents; immunosuppressants; antiallergens; antiinflammatory agents
10/25/2005US6958332 Treating an interleukin-12 overproduction-related disorder; treating rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis, psoriasis, or insulin-dependent diabetes mellitus
10/25/2005US6958331 sulfonyl amine derivatives such as {2-(2,2-diphenyl-ethylamino)-5-[4-(4-isopropyl-piperazine-1-carbonyl)-piperidine-1-sulfonyl]-phenyl}-morpholin-4-yl-methanone; pain, inflammation, septic shock
10/25/2005US6958220 Inhibitors of proteasomal activity for stimulating hair growth
10/25/2005US6958159 Pharmaceutical gel composition
10/25/2005US6958153 topical formulation of azithromycin / clarithromycin macrocyclic lactone antibiotic or Tacrolimus/ Sirolimus immunosuppressive macrolide and permeation modulator; minimizes systemic exposure treating at site reduced side effects; scalp conditions
10/25/2005CA2359708C Ketolide antibiotics
10/25/2005CA2331053C Compositions and methods for treating conditions responsive to estrogen
10/20/2005WO2005097996A1 Novel mite allergen
10/20/2005WO2005097814A2 Composition and method for inhibiting platelet aggregation
10/20/2005WO2005097775A1 Piperidine derivates for the treatment of chemokines mediared disease
10/20/2005WO2005097152A1 Turmeric extract-containing composition having improved caking capacity
10/20/2005WO2005097121A1 Angiogenesis-affecting compounds and methods of use thereof
10/20/2005WO2002097033A3 Antibodies that immunospecifically bind to trail receptors
10/20/2005US20050234248 Method of producing preparations rich in tocotrienol
10/20/2005US20050234129 Salts of nateglinide
10/20/2005US20050234118 Novel aryllimidazole derivatives, preparation and therapeutic used thereof
10/20/2005US20050234117 and geranylgeranyltransferase inhibitor; 3-chloromethyl-4-cyanobenzyl-5 methyl triazole; antitumor agents; prevent membrane attachment of protein p21ras and block aberrant growth of ras-transformed tumors; capable to inhibit prenylation of Ras proteins, both at enzymatic and cellular level
10/20/2005US20050234107 Use of diuretics for treating swellings
10/20/2005US20050234105 Method of treating of demyelinating diseases or conditions
10/20/2005US20050234090 Modulators of chemokine receptor activity
10/20/2005US20050234088 Urea substituted imidazoquinoline ethers
10/20/2005US20050234081 for inhibiting the enzyme C1s, a protease in the classical pathway of the complement system; and the use of this inhibition to treat or ameliorate acute or chronic disorders in mammals
10/20/2005US20050234079 Novel crystalline form of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl]methoxy] benzyl]thiazolidine-2,4-dione potassium salt
10/20/2005US20050234077 Pyrimidine compounds and their use as modulators of chemokine receptor activity
10/20/2005US20050234062 Such as 2-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,8,8a-tetrahydro-1H-phthalazin-2-yl]-piperidin-1-yl}-2H-acetamide; phosphodiesterase inhibitors; for treatment of respiratory disorders
10/20/2005US20050234061 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/20/2005US20050234056 Imidazoquinoline derivatives as adenosine A3 receptor ligands
10/20/2005US20050234051 5-Substituted 2-aryl-4 pyrimidinones
10/20/2005US20050234041 Substituted 1-benzazepines and derivatives thereof
10/20/2005US20050234036 3-(2-tetrahydrofuryl-methyl)-2-thioxanthine; neuroinflammatory disorders; pain, cancers, rheumatic arthritis, neurodegenerative diseases
10/20/2005US20050234032 Antibacterial compositions comprising metal phthalocyanine analogues
10/20/2005US20050234029 Compounds
10/20/2005US20050234028 solid dosage form for contraceptives and hormone replacement therapy; very low moisture content to prevent ester hydrolysis; enhanced bioavailability of 17-beta-estradiol
10/20/2005US20050234023 Phosphorylated glyceryl ether aluminum salt
10/20/2005US20050234022 Use of 2-alkoxyphenyl-substituted imidazotriazinones
10/20/2005US20050234017 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
10/20/2005US20050234011 Re-epithelializing pharmaceutical compositions comprising xanthan gum
10/20/2005US20050233999 That contain unmethylated cytosine-guanine (CpG) dinucleotides; stimulate an immune response and to redirect a Th2 response to a Th1 response; use with vaccines
10/20/2005US20050233995 Immunostimulatory nucleic acid molecules
10/20/2005US20050233955 Stimulation of nerve cell regeneration
10/20/2005US20050233447 A cell simultaneously expressing albumin protein and a membrane-associated CD14 surface antigen; expresses a mRNA sequence typical of hepatocytes selected from the group consisting of alpha-fetoprotein, carbamyl phosphate synthetase I, coagulation factor II, and coagulation factor VII
10/20/2005US20050233402 Heparinase III HLGAG fragments and uses thereof
10/20/2005US20050233328 Methods of identifying compounds that modulate protein activity
10/20/2005US20050233012 Hair growth stimulants for oral use
10/20/2005US20050232891 Methods of treating skin with diphosphonate derivatives
10/20/2005CA2563887A1 Mite allergen zen 1
10/20/2005CA2562223A1 Treatment of autoimmune disorders of the skin with a goat serum obtained from a goat challenged with hiv immunogen
10/20/2005CA2561958A1 Composition and method for inhibiting platelet aggregation
10/20/2005CA2560416A1 Angiogenesis-affecting compounds and methods of use thereof
10/20/2005CA2560311A1 Protein kinase c inhibitors for the treatment of autoimmune diseases and of transplant rejection
10/19/2005EP1586571A1 Dipeptidyl peptidase inhibitors
10/19/2005EP1586567A1 Compounds useful in the treatment of inflammatory diseases
10/19/2005EP1586315A1 Skin lightening composition
10/19/2005EP1585723A2 Modified retinoid compounds and their uses
10/19/2005EP1585713A1 New stilbene derivatives and their use as aryl hydrocarbon receptor ligand antagonists
10/19/2005EP1585534A2 Composition comprising an extract of aphanizomenon flos-aquae, use thereof and preparation of same
10/19/2005EP1585532A2 Topical anti-infective formulations
10/19/2005EP1585526A2 Novel use of mifepristone and derivatives thereof as hedgehog protein signalling pathway modulators and applications of same
10/19/2005EP1585494A1 Products and methods for maintaining or increasing ceramide levels in skin
10/19/2005EP1487272B1 Choline-silicic acid complex with osmolytes and divalent trace elements
10/19/2005EP1463714A4 Vanilloid receptor ligands and their use in treatments
10/19/2005EP1423117B1 2-substituted 1-arylpiperazines as tachykinin antagonists and/or serotonin reuptake inhibitors
10/19/2005EP1404656B9 Benzimidazole derivatives for treating microglia-activation associated diseases such as inflammatory, allergic, infectious or autoimmune diseases
10/19/2005EP1397170B1 Safety shield system for prefilled syringes
10/19/2005EP1370554B1 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors
10/19/2005EP1311263B1 Fused pyrrolocarbazoles against inflammation
10/19/2005EP1307245B1 Pharmaceutical form comprising a cell regulating factor and/or a cell proliferation promoter
10/19/2005EP1292340B1 Transfection system
10/19/2005EP1273299B1 Minoxidil-containing preparations
10/19/2005EP1269972B1 Hair growth stimulant compositions with sustained action
10/19/2005EP1109570B1 Modulation of memory effector t-cells with a cd2 binding agent
10/19/2005CN1684966A Novel adenine compound and use thereof
10/19/2005CN1684959A 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as C-KIT inhibitors
10/19/2005CN1684957A Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors
10/19/2005CN1684953A 吡唑化合物 Pyrazole compounds
10/19/2005CN1684952A Novel piperidine derivatives for use in the treatment of chemokine mediated disease states
10/19/2005CN1684708A Anti-NGF antibodies for the treatment of various disorders
10/19/2005CN1684705A Methods of use of compounds with preptin function
10/19/2005CN1684692A External preparation for inhibiting keloid formation
10/19/2005CN1684679A Preventive or remedy for bedsore
1 ... 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 ... 1065